Company Overview and News

Change in Market Lot Size of ADCC Infocad Limited (Scrip Code: 538734)

2017-08-08 indiainfoline
 This is in continuation of the Exchange Notice No 20170808-11 dated August 08, 2017 regarding the Bonus Issue of equity shares of ADCC Infocad Limited (Scrip Code: 538734) and SEBI circular no. CIR/MRD/DSA/06/2012 dated February 21, 2012 regarding the standardized lot size of securities of SME companies for the secondary market trading on SME Exchange/ Platform.

What to watch

2016-08-22 thehindubusinessline
The open offer to the shareholders of ADCC Infocad from its promoters opens on Tuesday. The offer is made to consolidate promoters’ holding in the company for effective management control. The promoter group, which currently owns 44.71 lakh shares (or 49.14 per cent) of the total paid-up equity share capital, plans to acquire 23.658 lakh shares (or 26 per cent) at ₹55 a share. The open offer ends on September 9.

ADCC Infocad to hold board meeting

2016-06-14 indiainfoline
We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits.

Open offer to keep ADCC Infocad in focus

2016-06-01 thehindubusinessline
Promoters of ADCC Infocad will make an open offer to buy 23.65 lakh shares (representing 26 per cent stake of the paid-up capital) from its public shareholders at ₹55 a share, payable in cash. Currently, promoters hold 45.38 per cent stake in the BSE-SME listed firm. The offer is aimed at consolidating promoters’ holding in ADCC Infocad. Seventeen HNIs own 17.97 per cent stake, while 152 individuals hold 4.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...